C
ADMA icon

Covestor’s ADMA Biologics ADMA Stock Holding History

Covestor’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16K Sell
1,937
-1,638
-46% -$14.9K 0.01% 1258
2026
Q1 		$32K Sell
3,575
-4,755
-57% -$75K 0.02% 927
2025
Q4 		$152K Buy
8,330
+7,856
+1,657% +$132K 0.08% 330
2025
Q3 		$7K Hold
474
– – ﹤0.01% 1782
2025
Q2 		$9K Buy
474
+461
+3,546% +$9.4K 0.01% 1623
2025
Q1 		$0 Sell
13
-5,983
-100% -$103K ﹤0.01% 2155
2024
Q4 		$103K Buy
5,996
+5,912
+7,038% +$111K 0.06% 506
2024
Q3 		$2K Sell
84
-44
-34% -$684 ﹤0.01% 1785
2024
Q2 		$1K Buy
+128
New +$1.07K ﹤0.01% 1908

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Covestor's ADMA Position: Q2 2026 in Review

Covestor reduced its ADMA Biologics (ADMA) stake by 46% in Q2 2026, selling an estimated $14.9K and leaving 1,937 shares worth $16K. The position accounts for 0.01% of the portfolio, ranked #1258.

Covestor first reported a position in ADMA in Q2 2024 and has held it in 9 quarters since. The position peaked at $152K in Q4 2025. 163 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • Covestor held 1,937 shares of ADMA Biologics worth $16K as of Q2 2026.
  • Covestor sold 1,638 ADMA Biologics shares in Q2 2026, an estimated $14.9K.
  • ADMA Biologics made up 0.01% of Covestor's portfolio in Q2 2026, its #1258 holding.
  • Covestor first reported a position in ADMA Biologics in Q2 2024 and has held it in 9 quarters since.
  • Covestor's ADMA Biologics position peaked at $152K in Q4 2025.
  • 163 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.